Compare Agilent Technologies Inc (A) vs Allegion PLC (ALLE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs Allegion PLC — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while Allegion PLC trades at $168.66 (market cap $14.08B). The key difference: Agilent Technologies Inc is far larger — about 3× Allegion PLC's market cap, and Allegion PLC pays the higher dividend (1.28%). Which is the better fit depends on your goals.
| A | ALLE | |
|---|---|---|
Market Cap | $42.00B | $14.08B |
Sector | Health | Industrials |
52-Week High | $157.20 | $179.77 |
52-Week Low | $110.24 | $125.65 |
Enterprise Value | $43.55B | $15.79B |
Dividend Yield | 0.69% | 1.28% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
ALLE trades at $168.94, up 0.14% today, near its consensus price target of $156. The stock shows bullish technical signals with strong moving averages, though RSI indicates overbought conditions. Recent Q2 2026 earnings beat expectations with EPS of $2.40 and revenue growth of 13% year-over-year, driven by Americas segment strength. The company raised full-year guidance, reflecting robust demand in residential and non-residential markets.
Outlook remains positive due to earnings momentum and raised guidance, but risks include high valuation multiples and reliance on Americas growth. Analysts are mixed with 30% buy ratings; institutional buying supports confidence. Key resistance is at $171, with support at $167.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Allegion PLC
Allegion is a global security products company with a portfolio of leading brands, such as Schlage, von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2021, Allegion generated 68% of sales in the United States. The company mainly competes with Swedish-based Assa Abloy AB and Switzerland-based Dormakaba.
Read more on ALLE →
